Study summary

A progranulin-boosting pill was safe, with early signs of slower progression

AZP2006 phase 2a · 36 people, phase 2a · Published December 2025, Movement Disorders

What was tested

AZP2006, a once-daily pill that stabilizes progranulin (a protein that supports brain cell clean-up), at two doses against placebo for 12 weeks, plus a 6-month open-label extension.

What they found

What it means

Supports a larger trial.

Mov Disord, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.